JCO Oncology Practice · 2023 · 20 citations · 28 references
MedicineOncologyPharmacologyCancer ControlOncology PharmacotherapyDose Adjustment In OncologyDose EscalationDose Modification StrategiesDose OptimizationDose SchedulingDose SelectionChemotherapy Dosing AdjustmentsDose Regimen SelectionHuman Health EffectsIntermittent Dosing RegimensTherapy SchedulingToxicity-driven Dose Reduction
PURPOSE: Cancer care-related greenhouse gas (GHG) emissions harm human health. Many cancer drugs are administered at greater-than-necessary doses, frequencies, and durations. Alternative dosing strategies may enable reductions in cancer care GHG emissions without compromising patient outcomes. MATERIALS AND METHODS: ) on bystanders for each alternative dosing strategy. RESULTS: Compared with the trastuzumab dosing strategy commonly used at baseline (12-month duration of adjuvant therapy and once every 3-week dosing in all settings), adoption of both 6-month adjuvant trastuzumab and once every 4-week trastuzumab dosing would reduce GHG emissions by 4.5%, 18.7%, and 14.6% in the neoadjuvant, adjuvant, and metastatic settings, respectively. We estimate that US-based adoption of alternative trastuzumab dosing would reduce annual DALYs and excess lives lost due to environmental impact of US-based trastuzumab therapy for HER2+ breast cancer by 1.5 and 0.9, respectively. CONCLUSION: Alternative dosing strategies may materially reduce the population health impacts of cancer care by reducing environmental impact. Regulatory decision making and health technology assessments should consider a treatment's environmental and population health impacts. Clinical trials of alternative dosing strategies are justified on the basis of environmental and population health impacts.
28
The environmental footprint of health care: a global assessment
Manfred Lenzen, Arunima Malik, Mengyu Li et al. · The Lancet Planetary Health · 2020 · 1.1K citations · Full text
Management, Environmental Sciences, Health Care Management +13
Edith A. Perez, Edward H. Romond, Vera J. Suman et al. · Journal of Clinical Oncology · 2011 · 718 citations · Full text
Medicine, Oncology, Pharmacology +17